Texas Top Legal Officer Files Lawsuit Against Tylenol Producers Over Autism Claims

The top legal official in Texas Paxton is filing a lawsuit against the makers of Tylenol, alleging the companies withheld safety concerns that the medication created to children's neurological development.

The court filing comes a month after President Donald Trump publicized an unsubstantiated connection between taking Tylenol - alternatively called acetaminophen - while pregnant and autism in children.

Paxton is filing suit against Johnson & Johnson, which previously sold the medication, the only pain reliever suggested for expectant mothers, and Kenvue, which currently produces it.

In a declaration, he claimed they "deceived the public by profiting off of discomfort and pushing pills without regard for the potential hazards."

The manufacturer asserts there is insufficient reliable data tying acetaminophen to autism.

"These manufacturers misled for generations, knowingly endangering millions to line their pockets," Paxton, a Republican, said.

The company stated officially that it was "deeply concerned by the spread of false claims on the security of paracetamol and the likely effects that could have on the welfare of women and children in America."

On its official site, the company also stated it had "continuously evaluated the pertinent research and there is insufficient valid information that shows a proven link between consuming acetaminophen and autism spectrum disorder."

Organizations representing medical professionals and healthcare providers share this view.

The leading OB-GYN organization has declared paracetamol - the main ingredient in Tylenol - is among limited choices for pregnant women to manage pain and fever, which can create serious health risks if left untreated.

"In multiple decades of studies on the utilization of acetaminophen in gestation, zero credible investigations has successfully concluded that the use of paracetamol in any trimester of gestation results in neurological conditions in young ones," the association stated.

The lawsuit cites recent announcements from the Trump administration in claiming the medication is reportedly hazardous.

In recent weeks, the former president raised alarms from public health officials when he advised women during pregnancy to "fight like hell" not to consume acetaminophen when sick.

The US Food and Drug Administration then published an announcement that medical professionals should consider limiting the usage of acetaminophen, while also stating that "a causal relationship" between the drug and autism spectrum disorder in children has remains unverified.

The Health Department head Kennedy, who manages the Food and Drug Administration, had promised in spring to initiate "a massive testing and research effort" that would establish the origin of autism in a short period.

But authorities advised that identifying a sole reason of autism spectrum disorder - considered by experts to be the result of a complex mix of genetic and external influences - would be difficult.

Autism is a form of enduring cognitive variation and disability that affects how persons experience and relate to the environment, and is identified using physician assessments.

In his lawsuit, Paxton - who supports Trump who is running for federal office - alleges Kenvue and J&J "willfully ignored and attempted to silence the research" around acetaminophen and autism spectrum disorder.

This legal action aims to force the corporations "remove any commercial messaging" that states acetaminophen is secure for women during pregnancy.

The Texas lawsuit mirrors the complaints of a group of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in recently.

A federal judge dismissed the case, declaring studies from the plaintiffs' authorities was inconclusive.